Log in to save to my catalogue

Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesoth...

Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesoth...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1880084973

Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

About this item

Full title

Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Publisher

Cham: Springer International Publishing

Journal title

Annals of surgical oncology, 2017-08, Vol.24 (8), p.2259-2265

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
This study was designed to determine the clinical significance of preoperative thrombocytosis in patients with malignant peritoneal mesothelioma (MPM) undergoing operative cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). CRS and HIPEC have been associated with prolonged survival in patients with MPM and is th...

Alternative Titles

Full title

Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1880084973

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1880084973

Other Identifiers

ISSN

1068-9265

E-ISSN

1534-4681

DOI

10.1245/s10434-017-5834-2

How to access this item